Qualitative Study on the Psychological Experience of Cancer Patients after Withdrawing from Drug Clinical Trials
10.12026/j.issn.1001-8565.2023.06.06
- VernacularTitle:肿瘤患者退出药物临床试验后心理体验的质性研究
- Author:
Yihong JIANG
1
;
Jinhong YANG
2
;
Yanfen LI
2
;
Tingting WANG
2
;
Shujuan CHEN
1
;
Yuxiu LIU
1
Author Information
1. School of Nursing, Weifang Medical University, Weifang 261053, China
2. Department of Oncology, Weifang People’s Hospital, Weifang 261041, China
- Publication Type:Journal Article
- Keywords:
Cancer Patients;
Clinical Trials;
Psychological Experience;
Humanistic Care
- From:
Chinese Medical Ethics
2023;36(6):624-629
- CountryChina
- Language:Chinese
-
Abstract:
【Objective:】 To understand the real psychological feelings of cancer patients after withdrawing from drug clinical trials, and provide reference for clinical healthcare professionals to serve personalized care for patients in the transitional period after withdrawing from drug clinical trials. 【Methods:】 With the descriptive phenomenology method, 11 subjects who withdrew from drug clinical trials in the oncology department of a tertiary hospital in Shandong Province were selected by intentional sampling method to conduct semi-structured in-depth interviews. Colaizzi seven-step analysis method was used to analyze and sort out records, and refine themes. 【Results:】 The psychological experiences of cancer patients after withdrawing from drug clinical trials were summarized into four themes: benefits of participating in clinical trials, losses of withdrawing from clinical trials, attitudes towards future treatment, and expectations of receiving help. 【Conclusion:】 Cancer patients face great psychological pressure after withdrawing from drug clinical trials and require deep emotional support and humanistic care. Nursing staff should take personalized care measures to meet the special problems of patients’ psychological needs, so as to help patients smoothly pass through the withdrawal stage and enter subsequent treatment.
